Amgen Inc.

AMGN

Healthcare

$326.98

2.95%Fair Value

Amgen Inc. (AMGN) is a Healthcare company that currently yields 2.95% — trading near fair value based on 10 years of dividend yield history. The Weiss valuation model places the undervaluation threshold at $264.03 and the overvaluation threshold at $348.82. Amgen Inc. holds a quality score of 59/100 (Average), reflecting 9 consecutive years of dividend growth with a 67% payout ratio. The 5-year dividend CAGR stands at 8.3%.

AMGN Dividend Yield History — Weiss Valuation

Underval. $264.03Overval. $348.82

Price

Undervalued band

Overvalued band

Why Now?

Amgen Inc. is trading at a fair valuation relative to its dividend history.

Current yield 3.0% vs historical max 3.7% (81% of maximum).

9 years of uninterrupted dividends.

Reasonable payout ratio of 67%.

Dividend Compounder (DRIP)

Initial Investment

Horizon (years)

Div. CAGR (%)

Year 1 Income

$320

Year 10 Income

$974

Yield on Cost

10.38%

Total Income

$5,824

Assumes dividends reinvested at current price. Simplified model — for illustrative purposes only.

Quality Score

Average

Payout Ratio12/25

Dividend Streak12/25

Growth (CAGR 5Y)20/20

Yield vs History10/15

FCF Coverage5/15

Key Metrics

Current Price$326.98

Annual Dividend$9.66

Current Yield2.95%

Yield — Max (10Y)3.66%

Yield — Min (10Y)2.77%

Undervalued Below$264.03

Overvalued Above$348.82

Payout Ratio67.22%

CAGR Dividend 5Y8.3%

CAGR Dividend 10Y—

Years No Cut9y

consecutive years of dividend growth

In-depth analysis

→ AMGN Dividend Analysis Article